Abstract
Background:
Osteopenia and osteoporosis are diseases frequently occurring after liver transplantation (OLT).
Purpose:
In a prospective study, we have investigated the effect of ibandronate, vitamin D(3), and calcium on the prevention and treatment of posttransplant osteopenia and osteoporosis.
Methods:
The bone mineral density (BMD) of the lumbar spine (LS) and of the femoral neck (FN) were measured in 74 patients prospectively pre- and post-OLT.
Results:
Postoperatively the study group showed a consistent percentage increase in BMD (g/cm(2)) and a significantly increased BMD after 12 and 24 months in the LS (12 months: 1.05 ± 0.21 g/cm(2); P < .001 24 months: 1.11 ± 0.19 g/cm(2); P < .001) and the FN (12 months: 0.88 ± 0.16 g/cm(2); P < .002 24 months: 0.90 ± 0.15 g/cm(2); P < .001) in comparison with baseline pre-OLT (LS pre-OLT 0.98 ± 0.19 g/cm(2), FN 0.86 ± 0.14 g/cm(2)). The overall bone fracture rate was 5.4% up to 24 months.
Conclusion:
Ibandronate once monthly per os significantly increased the BMD in the LS and FN after OLT at 12 and 24 months. The increased BMD limits the risk of fracture.
Copyright © 2012 Elsevier Inc. All rights reserved.
MeSH terms
-
Absorptiometry, Photon
-
Administration, Oral
-
Alkaline Phosphatase / blood
-
Amino Acids / urine
-
Biomarkers / blood
-
Biomarkers / urine
-
Bone Density / drug effects
-
Bone Density Conservation Agents / administration & dosage*
-
Bone Diseases, Metabolic / diagnostic imaging
-
Bone Diseases, Metabolic / etiology
-
Bone Diseases, Metabolic / metabolism
-
Bone Diseases, Metabolic / prevention & control*
-
Calcium / administration & dosage
-
Chi-Square Distribution
-
Cholecalciferol / administration & dosage
-
Creatinine / urine
-
Dietary Supplements
-
Diphosphonates / administration & dosage*
-
Drug Administration Schedule
-
Femur Neck / diagnostic imaging
-
Femur Neck / drug effects
-
Fractures, Bone / diagnostic imaging
-
Fractures, Bone / etiology
-
Fractures, Bone / metabolism
-
Fractures, Bone / prevention & control*
-
Germany
-
Humans
-
Ibandronic Acid
-
Liver Transplantation / adverse effects*
-
Lumbar Vertebrae / diagnostic imaging
-
Lumbar Vertebrae / drug effects
-
Osteoporosis / diagnostic imaging
-
Osteoporosis / etiology
-
Osteoporosis / metabolism
-
Osteoporosis / prevention & control*
-
Prospective Studies
-
Risk Assessment
-
Risk Factors
-
Time Factors
-
Treatment Outcome
Substances
-
Amino Acids
-
Biomarkers
-
Bone Density Conservation Agents
-
Diphosphonates
-
Cholecalciferol
-
pyridinoline
-
Creatinine
-
Alkaline Phosphatase
-
Calcium
-
Ibandronic Acid